Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Study was terminated due to difficulty in enrolling the targeted number of patients on March 1, 2005, last subject last visit date was Feb.16, 2005. There were no safety concerns involved in the decision to terminate the trial.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
confirmed diagnosis of schizophrenia according to DSM-IV-IV from patient's medical files
subjects with current treatment with typical or atypical neuroleptics which should be changed